Wall Street Analysts See a 764.18% Upside in Corbus Pharmaceuticals (CRBP): Can the Stock Really Move This High?

Corbus Pharmaceuticals (CRBP) closed the last trading session at $6.03, gaining 0.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 52.11 indicates a 764.2% upside potential.The mean estimate comprises nine short-term price targets with a standard deviation of $12.31. While the lowest estimate of$ 35 indicates a 480.4% increase from the current price level, the most optimistic an ...